Summary of biological research on hepatoblastoma: a scoping review
BackgroundHepatoblastoma is the most prevalent primary hepatic malignancy in children, comprising 80% of pediatric hepatic malignancies and 1% of all pediatric malignancies. However, traditional treatments have proven inadequate in effectively curing hepatoblastoma, leading to a poor prognosis.Metho...
Main Authors: | Huan-sheng Wang, Jing Lao, Ren-sen Jiang, Bin Wang, Xiao-peng Ma, Jian-yao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2024.1309693/full |
Similar Items
-
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma
by: Ruhi Gulati, et al.
Published: (2022-12-01) -
Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma
by: Wei-Ju Huang, et al.
Published: (2017-07-01) -
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
by: Jia-Feng Wu, et al.
Published: (2017-08-01) -
Mesenchymal hamartoma mimicking hepatoblastoma: A cytological pitfall
by: Deepti Verma, et al.
Published: (2015-01-01) -
Adult hepatoblastoma
by: Javier A. Cienfuegos, et al.